Rising KashmirRising KashmirRising Kashmir
  • Home
  • Top Stories
  • News
    • Kashmir
    • City
    • Jammu
    • Politics
  • Health
  • Anchor
  • Features
  • Interview
  • Video
Search

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022

Categories

  • Anchor
  • Breaking
  • Business
  • City
  • Developing Story
  • Editorial
  • Education
  • Features
  • Health
  • Interview
  • Jammu
  • Jammu and Kashmir News
  • Kashmir
  • Kashmir Tourism
  • Kath Bath
  • National
  • Opinion
  • Politics
  • Sports
  • Technology
  • Top Stories
  • Trending
  • Uncategorized
  • Video
  • Viewpoint
  • World
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Reading: SKIMS, Novo Nordisk sign MoU to boost clinical research in Kashmir
Share
Notification Show More
Font ResizerAa
Rising KashmirRising Kashmir
Font ResizerAa
  • Home
  • Top Stories
  • News
  • Health
  • Anchor
  • Features
  • Interview
  • Video
Search
  • Home
  • Top Stories
  • News
    • Kashmir
    • City
    • Jammu
    • Politics
  • Health
  • Anchor
  • Features
  • Interview
  • Video
Follow US
© 2024. All Rights Reserved.
Rising Kashmir > Blog > City > SKIMS, Novo Nordisk sign MoU to boost clinical research in Kashmir
City

SKIMS, Novo Nordisk sign MoU to boost clinical research in Kashmir

We aim to create transformative healthcare solutions: Dr Maya Sharma

M Peerzada
Last updated: December 12, 2024 12:14 am
M Peerzada
Published: December 12, 2024
Share
4 Min Read
SHARE

Srinagar, Dec 11: Novo Nordisk India Pvt. Ltd. and Sher-e-Kashmir Institute of Medical Sciences (SKIMS), Soura on Wednesday signed a Memorandum of Understanding (MoU) to establish a state-of-the-art Clinical Trial Unit (CTU) to strengthen clinical research under the aegis of the institute’s Clinical Research Department.
This partnership marks a significant milestone for both organizations as they join to innovate and transform the clinical research landscape to improve patient outcomes.
Dr. Mohammad Ashraf Ganie, Director, SKIMS & EOSG; Dr. Shariq R. Masoodi, Dean Medical Faculty, SKIMS; Vikrant Shrotriya, Managing Director and Corporate Vice President, Novo Nordisk India Pvt. Ltd; Dr. Maya Sharma, Geetanjli Raghavan, Veranki Leela Bhargavi, Andrey Vasilenko and others were present at the event.
The proceeding of the MoU ceremony was moderated by Dr. Muzaffar Maqsood Wani, Professor of Nephrology, SKIMS emphasized the collaborative potential of this initiative.
Dr. Maya Sharma, Vice President Clinical Medical Regulatory, Novo Nordisk India Pvt. Ltd. said that this partnership is aimed to redefine the future of clinical research in India.
“By uniting our global expertise in innovative therapeutics with SKIMS’ exceptional medical infrastructure, we aim to create transformative healthcare solutions. This partnership aspires to bridge gaps in access to advanced medicines, delivering life-changing outcomes for patients in underserved communities and beyond,” Sharma said.
Director SKIMS Dr. Mohammad Ashraf Ganie said the move represents a significant step towards elevating clinical research standards in the region.
“By collaborating with Novo Nordisk India Pvt. Ltd., SKIMS aims to contribute to advancements in medical science while ensuring that the people of Jammu and Kashmir have access to world-class healthcare,” he said.
Dr. Ganie said the MoU will pave the way to create a dedicated infrastructure for conducting cutting-edge clinical trials, providing researchers and clinicians with the necessary resources to carry out high-quality research.
This is the first of its kind MoU for clinical trials with a medical institute in the region and is valid for three years and opens doors to long-term collaboration.
The director said the partnership aims to explore solutions in cardiology, obesity, nephrology and rare diseases by leveraging Novo Nordisk’s expertise in developing advanced therapeutics and SKIMS’ robust medical infrastructure.
As part of the MoU, Novo Nordisk will contribute to building research capacity by providing resources, clinical research, relevant training and project-related equipment.
Officials said it aims to enhance the capabilities of the clinical research team at SKIMS, ensuring the outreach of life-saving medicines to a larger patient population.
Meanwhile, SKIMS will play a pivotal role in expediting the approval process for clinical trials, facilitating patient participation, care and ensuring their safety and convenience.
“Together, the two organizations aim to pave the way for therapeutic interventions, ensuring that world-class treatments reach those who need them most and setting a strong foundation for future advancements in Indian healthcare,” they said.

 

Late night inspection: DC Srinagar checks Shri Amarnath ji Yatra arrangements
Awareness program on food safety, balanced nutrition held GHS Institute Delina
KU faculty joins national-level rural development review mission
 Khyber Cement Powers Kashmiri Rowers Towards National, Global Glory
BSF’s Kashmir Frontier celebrates 60th Raising Day in Srinagar

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Whatsapp Whatsapp Copy Link Print
Previous Article Max Hospital Dwarka, Kashmir Clinics Group launch Multi-Speciality OPD in Sgr
Next Article Early detection critical for cancer prevention: Dr Fazili  
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

1MFollowersLike
262kFollowersFollow
InstagramFollow
234kSubscribersSubscribe
Google NewsFollow

Latest News

PM Modi arrives in Calgary to attend 51st G7 Summit in Alberta
Breaking National
June 17, 2025
“Everyone should immediately evacuate Tehran!”: Donald Trump
Breaking World
June 17, 2025
Tourism Impact on Heritage
Editorial
June 17, 2025
PM awarded highest civilian honour of Cyprus
Top Stories
June 17, 2025

Recent Posts

  • PM Modi arrives in Calgary to attend 51st G7 Summit in Alberta
  • “Everyone should immediately evacuate Tehran!”: Donald Trump
  • Tourism Impact on Heritage
  • PM awarded highest civilian honour of Cyprus
  • Amit Shah congratulates PM Modi for Cyprus’s highest award

Recent Comments

  1. Shah on Relief for Employees: J&K Bank Fixes EMI-Credit Mismatch, says JK Bank Chairman
  2. Latif khan on Why Kashmir needs Stronger Private Healthcare and Health Insurance
  3. Sameer farooq mir on Qazi Irfan assumes charge as RTO Kashmir
  4. Captain Vikrama on CM Omar Abdullah hails historic feat as three Kashmiri Girls crack IIT-JEE Advanced
  5. BASHIR AHMAD BHAT on Poor hotel accommodation, lack of medical facilities irk Kashmiri pilgrims in Saudi Arabia, video goes viral

Contact Us

Flat No 7,Press Enclave, Srinagar, 190001
0194 2477887
9971795706
[email protected]
[email protected]

Quick Link

  • E-Paper
  • About Us
  • Contact Us

Top Categories

Stay Connected

1.06MLike
262.5kFollow
InstagramFollow
234.3kSubscribe
WhatsAppFollow
Rising KashmirRising Kashmir
Follow US
© 2025. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?